Click for best price
Biosimilars & Followonbiologics Market Size, Share 2023
| Market size in 2022 |
US$ 9560.2 million
|
Forecast Market size by 2029 |
US$ 11700 million
|
| Growth Rate |
CAGR of 2.9% |
Number of Pages |
65 Pages |
This report aims to provide a comprehensive presentation of the global market for Biosimilars & Follow-on-biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilars & Follow-on-biologics. This report contains market size and forecasts of Biosimilars & Follow-on-biologics in global, including the following market information:
Global Biosimilars & Follow-on-biologics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Biosimilars & Follow-on-biologics market was valued at US$ 9560.2 million in 2022 and is projected to reach US$ 11700 million by 2029, at a CAGR of 2.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biosimilars or follow-on-biologics are the ?copied? and licensed versions of those reference biologics that have undergone patent expiration. Biosimilars development and validation with reference biologics is a crucial aspect of the overall development process.?
We surveyed the Biosimilars & Follow-on-biologics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilars & Follow-on-biologics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biosimilars & Follow-on-biologics Market Segment Percentages, by Type, 2022 (%)
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Global Biosimilars & Follow-on-biologics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biosimilars & Follow-on-biologics Market Segment Percentages, by Application, 2022 (%)
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Global Biosimilars & Follow-on-biologics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biosimilars & Follow-on-biologics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilars & Follow-on-biologics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biosimilars & Follow-on-biologics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biosimilars & Follow-on-biologics, market overview.
Chapter 2: Global Biosimilars & Follow-on-biologics market size in revenue.
Chapter 3: Detailed analysis of Biosimilars & Follow-on-biologics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biosimilars & Follow-on-biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Biosimilars & Follow-on-biologics Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 9560.2 million
|
| Forecast Market size by 2029 |
US$ 11700 million
|
| Growth Rate |
CAGR of 2.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biosimilars & Follow-on-biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars & Follow-on-biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars & Follow-on-biologics Overall Market Size
2.1 Global Biosimilars & Follow-on-biologics Market Size: 2022 VS 2029
2.2 Global Biosimilars & Follow-on-biologics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilars & Follow-on-biologics Players in Global Market
3.2 Top Global Biosimilars & Follow-on-biologics Companies Ranked by Revenue
3.3 Global Biosimilars & Follow-on-biologics Revenue by Companies
3.4 Top 3 and Top 5 Biosimilars & Follow-on-biologics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biosimilars & Follow-on-biologics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilars & Follow-on-biologics Players in Global Market
3.6.1 List of Global Tier 1 Biosimilars & Follow-on-biologics Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilars & Follow-on-biologics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilars & Follow-on-biologics Market Size Markets, 2022 & 2029
4.1.2 Human growth hormone
4.1.3 Erythropoietin
4.1.4 Monoclonal antibodies
4.1.5 Insulin
4.1.6 Interferon
4.1.7 Granulocyte-Colony Stimulating Factor
4.1.8 Others
4.2 By Type - Global Biosimilars & Follow-on-biologics Revenue & Forecasts
4.2.1 By Type - Global Biosimilars & Follow-on-biologics Revenue, 2018-2023
4.2.2 By Type - Global Biosimilars & Follow-on-biologics Revenue, 2024-2029
4.2.3 By Type - Global Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilars & Follow-on-biologics Market Size, 2022 & 2029
5.1.2 Blood Disorders
5.1.3 Oncology Diseases
5.1.4 Chronic and Autoimmune Diseases
5.1.5 Growth Hormone Deficiencies
5.1.6 Others
5.2 By Application - Global Biosimilars & Follow-on-biologics Revenue & Forecasts
5.2.1 By Application - Global Biosimilars & Follow-on-biologics Revenue, 2018-2023
5.2.2 By Application - Global Biosimilars & Follow-on-biologics Revenue, 2024-2029
5.2.3 By Application - Global Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Biosimilars & Follow-on-biologics Market Size, 2022 & 2029
6.2 By Region - Global Biosimilars & Follow-on-biologics Revenue & Forecasts
6.2.1 By Region - Global Biosimilars & Follow-on-biologics Revenue, 2018-2023
6.2.2 By Region - Global Biosimilars & Follow-on-biologics Revenue, 2024-2029
6.2.3 By Region - Global Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Biosimilars & Follow-on-biologics Revenue, 2018-2029
6.3.2 US Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.3.3 Canada Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.3.4 Mexico Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Biosimilars & Follow-on-biologics Revenue, 2018-2029
6.4.2 Germany Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.3 France Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.4 U.K. Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.5 Italy Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.6 Russia Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.7 Nordic Countries Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.8 Benelux Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Biosimilars & Follow-on-biologics Revenue, 2018-2029
6.5.2 China Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.5.3 Japan Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.5.4 South Korea Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.5.5 Southeast Asia Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.5.6 India Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Biosimilars & Follow-on-biologics Revenue, 2018-2029
6.6.2 Brazil Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.6.3 Argentina Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilars & Follow-on-biologics Revenue, 2018-2029
6.7.2 Turkey Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.7.3 Israel Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.7.4 Saudi Arabia Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.7.5 UAE Biosimilars & Follow-on-biologics Market Size, 2018-2029
7 Biosimilars & Follow-on-biologics Companies Profiles
7.1 Novartis (Sandoz)
7.1.1 Novartis (Sandoz) Company Summary
7.1.2 Novartis (Sandoz) Business Overview
7.1.3 Novartis (Sandoz) Biosimilars & Follow-on-biologics Major Product Offerings
7.1.4 Novartis (Sandoz) Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.1.5 Novartis (Sandoz) Key News & Latest Developments
7.2 Synthon Pharmaceuticals
7.2.1 Synthon Pharmaceuticals Company Summary
7.2.2 Synthon Pharmaceuticals Business Overview
7.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-biologics Major Product Offerings
7.2.4 Synthon Pharmaceuticals Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.2.5 Synthon Pharmaceuticals Key News & Latest Developments
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Company Summary
7.3.2 Teva Pharmaceutical Industries Business Overview
7.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-biologics Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.3.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.4 LG Life Sciences
7.4.1 LG Life Sciences Company Summary
7.4.2 LG Life Sciences Business Overview
7.4.3 LG Life Sciences Biosimilars & Follow-on-biologics Major Product Offerings
7.4.4 LG Life Sciences Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.4.5 LG Life Sciences Key News & Latest Developments
7.5 Celltrion Biocon
7.5.1 Celltrion Biocon Company Summary
7.5.2 Celltrion Biocon Business Overview
7.5.3 Celltrion Biocon Biosimilars & Follow-on-biologics Major Product Offerings
7.5.4 Celltrion Biocon Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.5.5 Celltrion Biocon Key News & Latest Developments
7.6 Hospira
7.6.1 Hospira Company Summary
7.6.2 Hospira Business Overview
7.6.3 Hospira Biosimilars & Follow-on-biologics Major Product Offerings
7.6.4 Hospira Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.6.5 Hospira Key News & Latest Developments
7.7 Merck Serono (Merck)
7.7.1 Merck Serono (Merck) Company Summary
7.7.2 Merck Serono (Merck) Business Overview
7.7.3 Merck Serono (Merck) Biosimilars & Follow-on-biologics Major Product Offerings
7.7.4 Merck Serono (Merck) Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.7.5 Merck Serono (Merck) Key News & Latest Developments
7.8 Biogen idec
7.8.1 Biogen idec Company Summary
7.8.2 Biogen idec Business Overview
7.8.3 Biogen idec Biosimilars & Follow-on-biologics Major Product Offerings
7.8.4 Biogen idec Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.8.5 Biogen idec Key News & Latest Developments
7.9 Genentech (Roche)
7.9.1 Genentech (Roche) Company Summary
7.9.2 Genentech (Roche) Business Overview
7.9.3 Genentech (Roche) Biosimilars & Follow-on-biologics Major Product Offerings
7.9.4 Genentech (Roche) Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.9.5 Genentech (Roche) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Biosimilars & Follow-on-biologics Market Opportunities & Trends in Global Market
Table 2. Biosimilars & Follow-on-biologics Market Drivers in Global Market
Table 3. Biosimilars & Follow-on-biologics Market Restraints in Global Market
Table 4. Key Players of Biosimilars & Follow-on-biologics in Global Market
Table 5. Top Biosimilars & Follow-on-biologics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Biosimilars & Follow-on-biologics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Biosimilars & Follow-on-biologics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Biosimilars & Follow-on-biologics Product Type
Table 9. List of Global Tier 1 Biosimilars & Follow-on-biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilars & Follow-on-biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Biosimilars & Follow-on-biologics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Biosimilars & Follow-on-biologics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Biosimilars & Follow-on-biologics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Biosimilars & Follow-on-biologics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Biosimilars & Follow-on-biologics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Biosimilars & Follow-on-biologics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2024-2029
Table 30. Novartis (Sandoz) Company Summary
Table 31. Novartis (Sandoz) Biosimilars & Follow-on-biologics Product Offerings
Table 32. Novartis (Sandoz) Biosimilars & Follow-on-biologics Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis (Sandoz) Key News & Latest Developments
Table 34. Synthon Pharmaceuticals Company Summary
Table 35. Synthon Pharmaceuticals Biosimilars & Follow-on-biologics Product Offerings
Table 36. Synthon Pharmaceuticals Biosimilars & Follow-on-biologics Revenue (US$, Mn) & (2018-2023)
Table 37. Synthon Pharmaceuticals Key News & Latest Developments
Table 38. Teva Pharmaceutical Industries Company Summary
Table 39. Teva Pharmaceutical Industries Biosimilars & Follow-on-biologics Product Offerings
Table 40. Teva Pharmaceutical Industries Biosimilars & Follow-on-biologics Revenue (US$, Mn) & (2018-2023)
Table 41. Teva Pharmaceutical Industries Key News & Latest Developments
Table 42. LG Life Sciences Company Summary
Table 43. LG Life Sciences Biosimilars & Follow-on-biologics Product Offerings
Table 44. LG Life Sciences Biosimilars & Follow-on-biologics Revenue (US$, Mn) & (2018-2023)
Table 45. LG Life Sciences Key News & Latest Developments
Table 46. Celltrion Biocon Company Summary
Table 47. Celltrion Biocon Biosimilars & Follow-on-biologics Product Offerings
Table 48. Celltrion Biocon Biosimilars & Follow-on-biologics Revenue (US$, Mn) & (2018-2023)
Table 49. Celltrion Biocon Key News & Latest Developments
Table 50. Hospira Company Summary
Table 51. Hospira Biosimilars & Follow-on-biologics Product Offerings
Table 52. Hospira Biosimilars & Follow-on-biologics Revenue (US$, Mn) & (2018-2023)
Table 53. Hospira Key News & Latest Developments
Table 54. Merck Serono (Merck) Company Summary
Table 55. Merck Serono (Merck) Biosimilars & Follow-on-biologics Product Offerings
Table 56. Merck Serono (Merck) Biosimilars & Follow-on-biologics Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Serono (Merck) Key News & Latest Developments
Table 58. Biogen idec Company Summary
Table 59. Biogen idec Biosimilars & Follow-on-biologics Product Offerings
Table 60. Biogen idec Biosimilars & Follow-on-biologics Revenue (US$, Mn) & (2018-2023)
Table 61. Biogen idec Key News & Latest Developments
Table 62. Genentech (Roche) Company Summary
Table 63. Genentech (Roche) Biosimilars & Follow-on-biologics Product Offerings
Table 64. Genentech (Roche) Biosimilars & Follow-on-biologics Revenue (US$, Mn) & (2018-2023)
Table 65. Genentech (Roche) Key News & Latest Developments
List of Figures
Figure 1. Biosimilars & Follow-on-biologics Segment by Type in 2022
Figure 2. Biosimilars & Follow-on-biologics Segment by Application in 2022
Figure 3. Global Biosimilars & Follow-on-biologics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biosimilars & Follow-on-biologics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biosimilars & Follow-on-biologics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biosimilars & Follow-on-biologics Revenue in 2022
Figure 8. By Type - Global Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
Figure 16. US Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
Figure 20. Germany Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 21. France Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
Figure 28. China Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 32. India Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
Figure 34. Brazil Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
Figure 37. Turkey Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Biosimilars & Follow-on-biologics Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis (Sandoz) Biosimilars & Follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Synthon Pharmaceuticals Biosimilars & Follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Teva Pharmaceutical Industries Biosimilars & Follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. LG Life Sciences Biosimilars & Follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celltrion Biocon Biosimilars & Follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Hospira Biosimilars & Follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Serono (Merck) Biosimilars & Follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Biogen idec Biosimilars & Follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Genentech (Roche) Biosimilars & Follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
